Any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells, according to a new study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the University of Michigan.
The finding strongly refutes the idea that embryonic stem cell research can be abandoned in favor of the less-controversial iPS cells, which are derived from adult human tissue.
“If federal funding stops for human embryonic stem cell research, it would have a serious negative impact on iPS cell research,” said Stanford
“Behind the embryonic stem cell war is just a war of patents,” led an article in the Osservatore Romano newspaper by Angelo Vescovi, a geneticist at the Niguarda Hospital in Milan and a professor at the Università Bicocca, who has always been against embryonic stem cell research and supporter of ‘law 40’ (recently declared unconstitutional by authorities).
“The production of embryonic stem cells by reprogramming adult cells discovered recently is not only better than methods that use human embryos, but is also based on new techniques, which are not protected by patents that currently govern the use of stem cells
American Doctors and Patients Challenge the FDA to Save Lives Rather Than Allow Patients to Needlessly Die
A couple of weeks ago, the American Stem Cell Therapy Association (ASCTA) was formed by a group of doctors, not to debate the pros and cons of embryonic stem cell research and adult stem cell research, but to […]
Stem Cell Research Study Reveals Stroke Patients Helped by Own Stem Cells
A new stem cell research study/trial recently completed shows that implanting a person’s own Adult Stem Cells helps stroke patients overcome partial paralysis. Dr. Kameshwar Prasad of the All India Institute of Medical Sciences (AIIMS) will present his stem cell study […]
Image via Wikipedia
Scientists have made a breakthrough in stem cell research which raises the prospect of regrowing damaged sections of a person’s liver, pancreas or even their brain.
Researchers at the University of NSW have found a way to improve the lifespan and competitiveness of stem cells, overcoming a problem which otherwise saw their regenerative powers fade in about an hour.
Adult stem cells were given a gene to make them resistant to chemotherapy, handing them an “advantage” when used to treat damaged tissue in conjunction with the cancer-fighting treatment.
University of NSW Professor Peter Gunning said as the chemotherapy cleaned out